InflaRx (IFRX) Gross Margin (2023 - 2025)

InflaRx's Gross Margin history spans 3 years, with the latest figure at 6645.49% for Q4 2025.

  • On a quarterly basis, Gross Margin fell 66033867.0% to 6645.49% in Q4 2025 year-over-year; TTM through Dec 2025 was 8600143.14%, a 859828789.0% decrease, with the full-year FY2025 number at 24677.94%, down 2277718.0% from a year prior.
  • Gross Margin hit 6645.49% in Q4 2025 for InflaRx, up from 172.9% in the prior quarter.
  • Over the last five years, Gross Margin for IFRX hit a ceiling of 666984.16% in Q4 2024 and a floor of 25781835.34% in Q1 2025.
  • Historically, Gross Margin has averaged 2792457.51% across 3 years, with a median of 511.93% in 2024.
  • Biggest five-year swings in Gross Margin: soared 67900778bps in 2024 and later tumbled 2000000000bps in 2025.
  • Tracing IFRX's Gross Margin over 3 years: stood at 12023.62% in 2023, then soared by 5647bps to 666984.16% in 2024, then tumbled by -99bps to 6645.49% in 2025.
  • Business Quant data shows Gross Margin for IFRX at 6645.49% in Q4 2025, 172.9% in Q3 2025, and 5985.37% in Q2 2025.